Johannes Waltenberger

Showing 1-3 of 3 articles

Coronary interventions

Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry

Waltenberger J, Brachmann J, Van der Heyden J, Richardt G, Fröbert O, Seige M, Erglis A, Dewilde W, Winkens M, Hegeler-Molkewehrum C, Klein N, Hoffmann S

February 19, 2016 | 10.4244/EIJY15M03_08

Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial

Duckers H, Houtgraaf J, Hehrlein C, Schofer J, Waltenberger J, Gershlick A, Bartunek J, Nienaber C, Naber C, Macaya C, Peters N, Smits P, Siminiak T, van Mieghem W, Legrand V, Serruys PW

February 21, 2011

A European multicentre, randomised study of the MAR-Tyn cobalt chromium tin-coated stent in patients with de novo coronary artery lesions: study design and protocol

Kastrati A, Balducelli M, Di Sciascio G, Moccetti T, Bortone A, Colombo A, Waltenberger J, Hehrlein C

April 12, 2010

1

Latest news

State-of-the-Art on Coronary Physiology; a Mini Focus on Biostatistics; Post-TAVI Aortic Manipulation; Minimally Invasive Ventricular Reconstruction after MI

Don't miss the next #EIJCardioChat!

IVUS-guided stenting in VIV-TAVI

This Week's JAA's: Deep Learning Model to Detect AMI, Mortality After Bleeding vs MI in CAD Patients...

New update: EXAMINATION 10 years, BIONYX 2 years, SAFE A, MASH and more

(Thanks to the support of Biotronik)

Optimising Physiological Endpoints of Percutaneous Coronary Intervention

Reducing refractory angina

Ranil de Silva et al.

Discover EuroIntervention's New Author Centre

Valvular disease